UNCY

Unicycive Therapeutics, Inc. Common Stock

6.20

USD

UNCY Earnings Reports

Positive Surprise Ratio

UNCY beat 7 of 18 last estimates.

39%

Next Report

Date of Next Report

Estimate for Q-- -- (Revenue/ EPS)

Implied change from Q3 25 (Revenue/ EPS)

Implied change from Q-- -- (Revenue/ EPS)

Unicycive Therapeutics, Inc. Common Stock earnings per share and revenue

On Nov 12, 2025, UNCY reported earnings of -0.33 USD per share (EPS) for Q3 25, beating the estimate of -0.56 USD, resulting in a 41.88% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +7.31% price change (close before vs. close after earnings).

Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

FAQ

What were Unicycive Therapeutics, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, Unicycive Therapeutics, Inc. Common Stock reported EPS of -$0.33, beating estimates by 41.88%, and revenue of $0.00, 0% as expectations.

How did the market react to Unicycive Therapeutics, Inc. Common Stock's Q3 2025 earnings?

The stock price moved up 7.31%, changed from $4.79 before the earnings release to $5.14 the day after.

When is Unicycive Therapeutics, Inc. Common Stock expected to report next?

The next earning report is scheduled for --.

What are the forecasts for Unicycive Therapeutics, Inc. Common Stock's next earnings report?

Based on -- analysts, Unicycive Therapeutics, Inc. Common Stock is expected to report EPS of -- and revenue of -- for Q-- --.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.